TreeWAS – Variant ID: rs1665050

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.007	0.993
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.009	0.991
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.023	0.977
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.038	0.962
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.043	0.957
T39.0 Salicylates	0.000	0.043	0.957
T39.1 4-Aminophenol derivatives	0.000	0.053	0.947
T42.4 Benzodiazepines	0.000	0.067	0.933
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.069	0.931
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.073	0.927
T40.2 Other opioids	0.000	0.082	0.918
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.091	0.909
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.102	0.898
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.109	0.891
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.156	0.844
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.168	0.832
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.187	0.813
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.201	0.799
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.215	0.785
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.219	0.781
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.221	0.779
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.230	0.770
T45.2 Vitamins, not elsewhere classified	0.000	0.250	0.750
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.258	0.742
T45.0 Antiallergic and antiemetic drugs	0.000	0.259	0.741
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.264	0.735
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.271	0.729
T42.3 Barbiturates	0.000	0.278	0.722
T42.1 Iminostilbenes	0.000	0.280	0.720
T39.4 Antirheumatics, not elsewhere classified	0.000	0.289	0.710
T39.2 Pyrazolone derivatives	0.000	0.289	0.710
T46.1 Calcium-channel blockers	0.000	0.293	0.707
T42.0 Hydantoin derivatives	0.000	0.293	0.706
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.299	0.701
T42.2 Succinimides and oxazolidinediones	0.000	0.299	0.701
T47.2 Stimulant laxatives	0.000	0.305	0.695
T40.5 Cocaine	0.000	0.307	0.693
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.308	0.692
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.310	0.689
T46.7 Peripheral vasodilators	0.000	0.310	0.689
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.319	0.680
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.320	0.680
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.322	0.678
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.327	0.673
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.329	0.670
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.332	0.667
T40.8 Lysergide [LSD]	0.000	0.332	0.667
T40.7 Cannabis (derivatives)	0.000	0.332	0.667
T40.0 Opium	0.000	0.332	0.667
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.335	0.665
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.335	0.665
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.335	0.665
T47.7 Emetics	0.000	0.335	0.665
T47.5 Digestants	0.000	0.335	0.665
T47.3 Saline and osmotic laxatives	0.000	0.335	0.665
T40.3 Methadone	0.000	0.335	0.665
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.341	0.659
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.341	0.659
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.346	0.654
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.348	0.652
T45.8 Other primarily systemic and haematological agents	0.000	0.348	0.652
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.348	0.652
T45.6 Fibrinolysis-affecting drugs	0.000	0.348	0.652
T45.3 Enzymes, not elsewhere classified	0.000	0.348	0.652
T47.6 Antidiarrhoeal drugs	0.000	0.353	0.646
T45.4 Iron and its compounds	0.000	0.362	0.638
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.368	0.632
T40.1 Heroin	0.000	0.368	0.632
T45.5 Anticoagulants	0.000	0.372	0.628
T47.0 Histamine H(2)-receptor antagonists	0.000	0.375	0.625
T36 Poisoning by systemic antibiotics	0.000	0.384	0.616
T47.4 Other laxatives	0.000	0.386	0.613
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.393	0.607
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.394	0.606
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.403	0.597
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.403	0.597
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.403	0.597
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.403	0.597
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.403	0.597
T44.0 Anticholinesterase agents	0.000	0.403	0.597
T49.9 Topical agent, unspecified	0.000	0.427	0.573
T49.8 Other topical agents	0.000	0.427	0.573
T49.7 Dental drugs, topically applied	0.000	0.427	0.573
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.427	0.573
T49.5 Ophthalmological drugs and preparations	0.000	0.427	0.573
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.427	0.573
T49.3 Emollients, demulcents and protectants	0.000	0.427	0.573
T49.2 Local astringents and local detergents	0.000	0.427	0.573
T49.1 Antipruritics	0.000	0.427	0.573
T43.6 Psychostimulants with abuse potential	0.000	0.436	0.564
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.437	0.563
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.440	0.559
T43.9 Psychotropic drug, unspecified	0.000	0.453	0.546
T40.6 Other and unspecified narcotics	0.000	0.456	0.544
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.457	0.543
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.480	0.519
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.497	0.503
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.501	0.498
T41.5 Therapeutic gases	0.000	0.512	0.488
T41.4 Anaesthetic, unspecified	0.000	0.512	0.488
T41.3 Local anaesthetics	0.000	0.512	0.488
T41.1 Intravenous anaesthetics	0.000	0.512	0.488
T41.0 Inhaled anaesthetics	0.000	0.512	0.488
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.512	0.487
T37.5 Antiviral drugs	0.000	0.512	0.487
T37.4 Anthelminthics	0.000	0.512	0.487
T37.3 Other antiprotozoal drugs	0.000	0.512	0.487
T37.1 Antimycobacterial drugs	0.000	0.512	0.487
T37.0 Sulphonamides	0.000	0.512	0.487
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.517	0.483
T48.4 Expectorants	0.000	0.517	0.483
T48.3 Antitussives	0.000	0.517	0.483
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.517	0.483
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.517	0.483
T48.0 Oxytocic drugs	0.000	0.517	0.483
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.523	0.477
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.529	0.471
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.533	0.466
T48.5 Anti-common-cold drugs	0.000	0.543	0.457
T41.2 Other and unspecified general anaesthetics	0.000	0.543	0.457
T50.4 Drugs affecting uric acid metabolism	0.000	0.545	0.455
T36.3 Macrolides	0.000	0.555	0.444
T36.9 Systemic antibiotic, unspecified	0.000	0.558	0.442
T36.7 Antifungal antibiotics, systemically used	0.000	0.558	0.442
T36.6 Rifamycins	0.000	0.558	0.442
T36.5 Aminoglycosides	0.000	0.558	0.442
T36.2 Chloramphenicol group	0.000	0.558	0.442
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.558	0.442
T36.8 Other systemic antibiotics	0.000	0.560	0.440
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.561	0.439
T50.7 Analeptics and opioid receptor antagonists	0.000	0.599	0.401
T50.5 Appetite depressants	0.000	0.599	0.401
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.599	0.401
T50.0 Mineralocorticoids and their antagonists	0.000	0.599	0.401
T36.4 Tetracyclines	0.000	0.599	0.401
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.600	0.400
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.601	0.399
T36.0 Penicillins	0.000	0.603	0.397
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.611	0.388
T50.1 Loop [high-ceiling] diuretics	0.000	0.634	0.366
T50.8 Diagnostic agents	0.000	0.639	0.361
T38.9 Other and unspecified hormone antagonists	0.000	0.639	0.361
T38.7 Androgens and anabolic congeners	0.000	0.639	0.361
T38.5 Other oestrogens and progestogens	0.000	0.639	0.361
T38.4 Oral contraceptives	0.000	0.639	0.361
T38.2 Antithyroid drugs	0.000	0.639	0.361
T38.1 Thyroid hormones and substitutes	0.000	0.651	0.348
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.652	0.348
T43.2 Other and unspecified antidepressants	0.000	0.666	0.334
T38.0 Glucocorticoids and synthetic analogues	0.001	0.670	0.330
T40.4 Other synthetic narcotics	0.001	0.673	0.326
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.797	0.202
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.840	0.160
D23.7 Skin of lower limb, including hip	0.038	0.962	0.000
M31.6 Other giant cell arteritis	0.024	0.976	0.000
M31.3 Wegener's granulomatosis	0.023	0.977	0.000
M31 Other necrotising vasculopathies	0.022	0.978	0.000
C77.2 Intra-abdominal lymph nodes	0.000	0.981	0.019
M31.9 Necrotising vasculopathy, unspecified	0.019	0.981	0.000
M31.7 Microscopic polyangiitis	0.018	0.981	0.000
M31.1 Thrombotic microangiopathy	0.018	0.982	0.000
M31.8 Other specified necrotising vasculopathies	0.017	0.983	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.016	0.984	0.000
M31.2 Lethal midline granuloma	0.016	0.984	0.000
M31.0 Hypersensitivity angiitis	0.015	0.985	0.000
O82.0 Delivery by elective Caesarean section	0.000	0.985	0.015
D25.0 Submucous leiomyoma of uterus	0.000	0.985	0.015
D25 Leiomyoma of uterus	0.000	0.986	0.014
D25.9 Leiomyoma of uterus, unspecified	0.000	0.986	0.014
D25.1 Intramural leiomyoma of uterus	0.000	0.986	0.014
M31.4 Aortic arch syndrome [Takayasu]	0.012	0.987	0.000
J98.4 Other disorders of lung	0.012	0.988	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.011	0.989	0.000
D25.2 Subserosal leiomyoma of uterus	0.000	0.990	0.010
O82 Single delivery by Caesarean section	0.000	0.991	0.009
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.000	0.991	0.009
O82.9 Delivery by Caesarean section, unspecified	0.000	0.991	0.009
C50.4 Upper-outer quadrant of breast	0.000	0.992	0.008
F00.9 Dementia in Alzheimer's disease, unspecified	0.008	0.992	0.000
O03.9 Complete or unspecified, without complication	0.000	0.992	0.008
Z45.1 Adjustment and management of infusion pump	0.000	0.992	0.008
G30.9 Alzheimer's disease, unspecified	0.008	0.992	0.000
Z32.0 Pregnancy, not (yet) confirmed	0.000	0.993	0.007
J98 Other respiratory disorders	0.007	0.993	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.000	0.993	0.007
J98.5 Diseases of mediastinum, not elsewhere classified	0.007	0.993	0.000
O82.8 Other single delivery by Caesarean section	0.000	0.993	0.007
O82.2 Delivery by Caesarean hysterectomy	0.000	0.993	0.007
J84.1 Other interstitial pulmonary diseases with fibrosis	0.007	0.993	0.000
J98.0 Diseases of bronchus, not elsewhere classified	0.007	0.993	0.000
K74.3 Primary biliary cirrhosis	0.006	0.994	0.000
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.000	0.994	0.006
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.994	0.006
J98.2 Interstitial emphysema	0.006	0.994	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.994	0.006
K74 Fibrosis and cirrhosis of liver	0.006	0.994	0.000
N85.2 Hypertrophy of uterus	0.000	0.994	0.006
J98.3 Compensatory emphysema	0.005	0.995	0.000
O03 Spontaneous abortion	0.000	0.995	0.005
K74.5 Biliary cirrhosis, unspecified	0.005	0.995	0.000
O03.4 Incomplete, without complication	0.000	0.995	0.005
K74.6 Other and unspecified cirrhosis of liver	0.005	0.995	0.000
J98.6 Disorders of diaphragm	0.005	0.995	0.000
J98.8 Other specified respiratory disorders	0.005	0.995	0.000
F06.7 Mild cognitive disorder	0.005	0.995	0.000
R77.8 Other specified abnormalities of plasma proteins	0.000	0.995	0.005
K51 Ulcerative colitis	0.000	0.995	0.005
N85 Other noninflammatory disorders of uterus, except cervix	0.000	0.995	0.005
O82.1 Delivery by emergency Caesarean section	0.000	0.995	0.004
J84 Other interstitial pulmonary diseases	0.005	0.995	0.000
K74.1 Hepatic sclerosis	0.004	0.995	0.000
J98.9 Respiratory disorder, unspecified	0.004	0.996	0.000
N85.9 Noninflammatory disorder of uterus, unspecified	0.000	0.996	0.004
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.996	0.004
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.996	0.004
K74.4 Secondary biliary cirrhosis	0.004	0.996	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.004	0.996	0.000
N85.7 Haematometra	0.000	0.996	0.004
F00 Dementia in Alzheimer's disease	0.004	0.996	0.000
O03.7 Complete or unspecified, complicated by embolism	0.000	0.996	0.004
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.996	0.004
O03.2 Incomplete, complicated by embolism	0.000	0.996	0.004
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.996	0.004
O03.8 Complete or unspecified, with other and unspecified complications	0.000	0.996	0.004
Z32 Pregnancy examination and test	0.000	0.996	0.004
K25.3 Acute without haemorrhage or perforation	0.000	0.996	0.004
K51.8 Other ulcerative colitis	0.000	0.996	0.004
J84.8 Other specified interstitial pulmonary diseases	0.004	0.996	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.996	0.004
O03.3 Incomplete, with other and unspecified complications	0.000	0.996	0.004
F20.9 Schizophrenia, unspecified	0.000	0.996	0.004
S02.40 Fracture of malar and maxillary bones (closed)	0.004	0.996	0.000
K74.0 Hepatic fibrosis	0.004	0.996	0.000
Z32.1 Pregnancy confirmed	0.000	0.996	0.004
J84.0 Alveolar and parietoalveolar conditions	0.004	0.996	0.000
N85.5 Inversion of uterus	0.000	0.996	0.004
N85.3 Subinvolution of uterus	0.000	0.996	0.004
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.004	0.996	0.000
O81.4 Vacuum extractor delivery	0.004	0.996	0.000
N85.6 Intra-uterine synechiae	0.000	0.996	0.004
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
G30 Alzheimer's disease	0.003	0.997	0.000
Z32.9 Pregnancy confirmed (erroneous code. See Z321)	0.000	0.997	0.003
M40.29 Other and unspecified kyphosis (Site unspecified)	0.000	0.997	0.003
N85.1 Endometrial adenomatous hyperplasia	0.000	0.997	0.003
K51.9 Ulcerative colitis, unspecified	0.000	0.997	0.003
F00.1 Dementia in Alzheimer's disease with late onset	0.003	0.997	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.997	0.003
J84.9 Interstitial pulmonary disease, unspecified	0.003	0.997	0.000
N72 Inflammatory disease of cervix uteri	0.000	0.997	0.003
K51.5 Mucosal proctocolitis	0.000	0.997	0.003
G30.8 Other Alzheimer's disease	0.003	0.997	0.000
J98.1 Pulmonary collapse	0.003	0.997	0.000
F06.3 Organic mood [affective] disorders	0.003	0.997	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.003	0.997	0.000
N18.2 Chronic kidney disease, stage 2	0.003	0.997	0.000
D35.1 Parathyroid gland	0.003	0.997	0.000
I69 Sequelae of cerebrovascular disease	0.003	0.997	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.003	0.997	0.000
F06.5 Organic dissociative disorder	0.003	0.997	0.000
F06.4 Organic anxiety disorder	0.003	0.997	0.000
F06.1 Organic catatonic disorder	0.003	0.997	0.000
F06.0 Organic hallucinosis	0.003	0.997	0.000
C32.1 Supraglottis	0.000	0.997	0.003
K51.4 Pseudopolyposis of colon	0.000	0.997	0.003
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
M40.24 Other and unspecified kyphosis (Thoracic region)	0.000	0.997	0.003
M40.2 Other and unspecified kyphosis	0.000	0.997	0.003
F00.0 Dementia in Alzheimer's disease with early onset	0.002	0.997	0.000
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.997	0.003
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.003	0.997	0.000
F20 Schizophrenia	0.000	0.997	0.003
N85.0 Endometrial glandular hyperplasia	0.000	0.998	0.002
G30.1 Alzheimer's disease with late onset	0.002	0.998	0.000
K92.2 Gastro-intestinal haemorrhage, unspecified	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.000	0.998	0.002
I69.0 Sequelae of subarachnoid haemorrhage	0.002	0.998	0.000
M40.26 Other and unspecified kyphosis (Lumbar region)	0.000	0.998	0.002
S02.4 Fracture of malar and maxillary bones	0.002	0.998	0.000
O00.1 Tubal pregnancy	0.000	0.998	0.002
C32.9 Larynx, unspecified	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.998	0.002
M40.25 Other and unspecified kyphosis (Thoracolumbar region)	0.000	0.998	0.002
M40.28 Other and unspecified kyphosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M40.27 Other and unspecified kyphosis (Lumbosacral region)	0.000	0.998	0.002
M40.23 Other and unspecified kyphosis (Cervicothoracic region)	0.000	0.998	0.002
M40.21 Other and unspecified kyphosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M40.20 Other and unspecified kyphosis (Multiple sites in spine)	0.000	0.998	0.002
S02.41 Fracture of malar and maxillary bones (open)	0.002	0.998	0.000
F20.5 Residual schizophrenia	0.000	0.998	0.002
N85.4 Malposition of uterus	0.002	0.998	0.000
U89.8 Agent resistant to other single specified antibiotic	0.002	0.998	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.998	0.002
O81 Single delivery by forceps and vacuum extractor	0.002	0.998	0.001
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.002	0.998	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.998	0.002
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.002	0.998	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.002	0.998	0.000
F20.6 Simple schizophrenia	0.000	0.998	0.002
F20.4 Postschizophrenic depression	0.000	0.998	0.002
F20.3 Undifferentiated schizophrenia	0.000	0.998	0.002
F20.1 Hebephrenic schizophrenia	0.000	0.998	0.002
H81.2 Vestibular neuronitis	0.000	0.998	0.002
G83.4 Cauda equina syndrome	0.000	0.998	0.002
G30.0 Alzheimer's disease with early onset	0.002	0.998	0.000
R77 Other abnormalities of plasma proteins	0.000	0.998	0.002
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.998	0.002
F20.2 Catatonic schizophrenia	0.000	0.998	0.002
S05.1 Contusion of eyeball and orbital tissues	0.000	0.998	0.002
J80-J84 Other respiratory diseases principally affecting the interstitium	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.000	0.998	0.002
M40.22 Other and unspecified kyphosis (Cervical region)	0.000	0.998	0.002
F20.8 Other schizophrenia	0.000	0.998	0.002
K29.1 Other acute gastritis	0.000	0.998	0.002
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.998	0.002
F00-F09 Organic, including symptomatic, mental disorders	0.002	0.998	0.000
K38.8 Other specified diseases of appendix	0.002	0.998	0.000
D63.0 Anaemia in neoplastic disease	0.002	0.998	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
J82 Pulmonary eosinophilia, not elsewhere classified	0.002	0.998	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.998	0.002
O81.5 Delivery by combination of forceps and vacuum extractor	0.001	0.998	0.001
O81.2 Mid-cavity forceps with rotation	0.001	0.998	0.001
O81.1 Mid-cavity forceps delivery	0.001	0.998	0.001
O81.3 Other and unspecified forceps delivery	0.001	0.998	0.000
K12.1 Other forms of stomatitis	0.000	0.998	0.002
R77.9 Abnormality of plasma protein, unspecified	0.000	0.998	0.002
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.002	0.998	0.000
S05.5 Penetrating wound of eyeball with foreign body	0.000	0.998	0.002
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.000	0.998	0.002
U89 Agent resistant to other and unspecified antibiotics	0.002	0.998	0.000
O81.0 Low forceps delivery	0.001	0.998	0.001
R77.2 Abnormality of alphafetoprotein	0.000	0.998	0.002
R77.1 Abnormality of globulin	0.000	0.998	0.002
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.000	0.998	0.002
S05 Injury of eye and orbit	0.000	0.998	0.002
C32.3 Laryngeal cartilage	0.000	0.998	0.002
I69.3 Sequelae of cerebral infarction	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.000	0.998	0.002
L12.9 Pemphigoid, unspecified	0.002	0.998	0.000
F02 Dementia in other diseases classified elsewhere	0.002	0.998	0.000
E66.8 Other obesity	0.002	0.998	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
D22.4 Melanocytic naevi of scalp and neck	0.000	0.998	0.002
M41.9 Scoliosis, unspecified	0.000	0.998	0.002
Z00.0 General medical examination	0.002	0.998	0.000
J80 Adult respiratory distress syndrome	0.002	0.998	0.000
U88 Agent resistant to multiple antibiotics	0.002	0.998	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.998	0.002
A63.0 Anogenital (venereal) warts	0.002	0.998	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
S64.4 Injury of digital nerve of other finger	0.000	0.998	0.002
M40 Kyphosis and lordosis	0.000	0.998	0.002
C32.0 Glottis	0.000	0.998	0.002
D61.9 Aplastic anaemia, unspecified	0.002	0.998	0.000
M20.5 Other deformities of toe(s) (acquired)	0.000	0.998	0.002
S05.8 Other injuries of eye and orbit	0.000	0.998	0.002
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.998	0.002
C32.2 Subglottis	0.000	0.998	0.001
H81.0 Meniere's disease	0.000	0.998	0.002
L12.1 Cicatricial pemphigoid	0.002	0.998	0.000
S73.0 Dislocation of hip	0.002	0.998	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.001	0.998	0.000
F02.0 Dementia in Pick's disease	0.001	0.998	0.000
F40.2 Specific (isolated) phobias	0.000	0.998	0.002
G81.9 Hemiplegia, unspecified	0.002	0.998	0.000
N95.3 States associated with artificial menopause	0.000	0.998	0.002
R77.0 Abnormality of albumin	0.000	0.998	0.001
S05.6 Penetrating wound of eyeball without foreign body	0.000	0.998	0.001
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.000	0.998	0.001
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.998	0.002
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.998	0.002
R45.8 Other symptoms and signs involving emotional state	0.000	0.998	0.002
S05.7 Avulsion of eye	0.000	0.998	0.001
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
O80-O84 Delivery	0.000	0.998	0.001
M41.92 Scoliosis, unspecified (Cervical region)	0.000	0.998	0.001
L12.0 Bullous pemphigoid	0.001	0.998	0.000
N81.8 Other female genital prolapse	0.002	0.998	0.000
F09 Unspecified organic or symptomatic mental disorder	0.001	0.998	0.000
H81 Disorders of vestibular function	0.000	0.998	0.002
N70 Salpingitis and oophoritis	0.000	0.998	0.002
S02.00 Fracture of vault of skull (closed)	0.001	0.998	0.000
D72.8 Other specified disorders of white blood cells	0.001	0.998	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.001	0.998	0.000
F02.2 Dementia in Huntington's disease	0.001	0.998	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.001	0.998	0.000
U89.9 Agent resistant to unspecified antibiotic	0.001	0.998	0.000
L12 Pemphigoid	0.001	0.998	0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.000	0.999	0.001
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.000	0.999	0.001
M92.6 Juvenile osteochondrosis of tarsus	0.001	0.999	0.000
S64.3 Injury of digital nerve of thumb	0.000	0.999	0.001
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.001	0.999	0.000
V23.4 Driver injured in traffic accident	0.001	0.999	0.000
F81 Specific developmental disorders of scholastic skills	0.000	0.999	0.001
I71 Aortic aneurysm and dissection	0.000	0.999	0.001
S36.80 Injury of other intra-abdominal organs (without open wound into cavity)	0.000	0.999	0.001
D37.5 Rectum	0.000	0.999	0.001
I87.8 Other specified disorders of veins	0.000	0.999	0.001
M40.4 Other lordosis	0.000	0.999	0.001
M40.3 Flatback syndrome	0.000	0.999	0.001
M40.0 Postural kyphosis	0.000	0.999	0.001
M40.5 Lordosis, unspecified	0.000	0.999	0.001
M40.1 Other secondary kyphosis	0.000	0.999	0.001
N70.0 Acute salpingitis and oophoritis	0.000	0.999	0.001
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.001	0.999	0.000
M40.52 Lordosis, unspecified (Cervical region)	0.000	0.999	0.001
C45.9 Mesothelioma, unspecified	0.001	0.999	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.001	0.999	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.999	0.001
M41.94 Scoliosis, unspecified (Thoracic region)	0.000	0.999	0.001
D47.2 Monoclonal gammopathy	0.000	0.999	0.001
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.001	0.999	0.000
F07.1 Postencephalitic syndrome	0.001	0.999	0.000
K42.0 Umbilical hernia with obstruction, without gangrene	0.001	0.999	0.000
F01 Vascular dementia	0.001	0.999	0.000
F01.1 Multi-infarct dementia	0.001	0.999	0.000
H81.9 Disorder of vestibular function, unspecified	0.000	0.999	0.001
F07.2 Postconcussional syndrome	0.001	0.999	0.000
K63.1 Perforation of intestine (nontraumatic)	0.000	0.999	0.001
S05.4 Penetrating wound of orbit with or without foreign body	0.000	0.999	0.001
O00 Ectopic pregnancy	0.000	0.999	0.001
O83 Other assisted single delivery	0.000	0.999	0.001
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.999	0.001
O84 Multiple delivery	0.000	0.999	0.001
F07.0 Organic personality disorder	0.001	0.999	0.000
H81.8 Other disorders of vestibular function	0.000	0.999	0.001
H81.4 Vertigo of central origin	0.000	0.999	0.001
H81.3 Other peripheral vertigo	0.000	0.999	0.001
L12.8 Other pemphigoid	0.001	0.999	0.000
L12.3 Acquired epidermolysis bullosa	0.001	0.999	0.000
L12.2 Chronic bullous disease of childhood	0.001	0.999	0.000
S00.9 Superficial injury of head, part unspecified	0.001	0.999	0.000
F81.8 Other developmental disorders of scholastic skills	0.000	0.999	0.001
F81.3 Mixed disorder of scholastic skills	0.000	0.999	0.001
F81.2 Specific disorder of arithmetical skills	0.000	0.999	0.001
F81.1 Specific spelling disorder	0.000	0.999	0.001
F81.0 Specific reading disorder	0.000	0.999	0.001
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.999	0.001
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.999	0.001
K73.2 Chronic active hepatitis, not elsewhere classified	0.001	0.999	0.000
S05.9 Injury of eye and orbit, part unspecified	0.000	0.999	0.001
M40.09 Postural kyphosis (Site unspecified)	0.000	0.999	0.001
M40.08 Postural kyphosis (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M40.07 Postural kyphosis (Lumbosacral region)	0.000	0.999	0.001
M40.06 Postural kyphosis (Lumbar region)	0.000	0.999	0.001
M40.05 Postural kyphosis (Thoracolumbar region)	0.000	0.999	0.001
M40.04 Postural kyphosis (Thoracic region)	0.000	0.999	0.001
M40.03 Postural kyphosis (Cervicothoracic region)	0.000	0.999	0.001
M40.02 Postural kyphosis (Cervical region)	0.000	0.999	0.001
M40.01 Postural kyphosis (Occipito-atlanto-axial region)	0.000	0.999	0.001
M40.00 Postural kyphosis (Multiple sites in spine)	0.000	0.999	0.001
M40.39 Flatback syndrome (Site unspecified)	0.000	0.999	0.001
M40.38 Flatback syndrome (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M40.37 Flatback syndrome (Lumbosacral region)	0.000	0.999	0.001
M40.36 Flatback syndrome (Lumbar region)	0.000	0.999	0.001
M40.35 Flatback syndrome (Thoracolumbar region)	0.000	0.999	0.001
M40.34 Flatback syndrome (Thoracic region)	0.000	0.999	0.001
M40.33 Flatback syndrome (Cervicothoracic region)	0.000	0.999	0.001
M40.32 Flatback syndrome (Cervical region)	0.000	0.999	0.001
M40.31 Flatback syndrome (Occipito-atlanto-axial region)	0.000	0.999	0.001
M40.30 Flatback syndrome (Multiple sites in spine)	0.000	0.999	0.001
M40.49 Other lordosis (Site unspecified)	0.000	0.999	0.001
M40.48 Other lordosis (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M40.47 Other lordosis (Lumbosacral region)	0.000	0.999	0.001
M40.46 Other lordosis (Lumbar region)	0.000	0.999	0.001
M40.45 Other lordosis (Thoracolumbar region)	0.000	0.999	0.001
M40.44 Other lordosis (Thoracic region)	0.000	0.999	0.001
M40.43 Other lordosis (Cervicothoracic region)	0.000	0.999	0.001
M40.42 Other lordosis (Cervical region)	0.000	0.999	0.001
M40.41 Other lordosis (Occipito-atlanto-axial region)	0.000	0.999	0.001
M40.40 Other lordosis (Multiple sites in spine)	0.000	0.999	0.001
M40.59 Lordosis, unspecified (Site unspecified)	0.000	0.999	0.001
M40.58 Lordosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M40.57 Lordosis, unspecified (Lumbosacral region)	0.000	0.999	0.001
M40.55 Lordosis, unspecified (Thoracolumbar region)	0.000	0.999	0.001
M40.54 Lordosis, unspecified (Thoracic region)	0.000	0.999	0.001
M40.53 Lordosis, unspecified (Cervicothoracic region)	0.000	0.999	0.001
M40.51 Lordosis, unspecified (Occipito-atlanto-axial region)	0.000	0.999	0.001
M40.50 Lordosis, unspecified (Multiple sites in spine)	0.000	0.999	0.001
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.999	0.001
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.999	0.001
Y83.9 Surgical procedure, unspecified	0.001	0.999	0.000
M40.19 Other secondary kyphosis (Site unspecified)	0.000	0.999	0.001
M40.18 Other secondary kyphosis (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M40.17 Other secondary kyphosis (Lumbosacral region)	0.000	0.999	0.001
M40.16 Other secondary kyphosis (Lumbar region)	0.000	0.999	0.001
M40.15 Other secondary kyphosis (Thoracolumbar region)	0.000	0.999	0.001
M40.14 Other secondary kyphosis (Thoracic region)	0.000	0.999	0.001
M40.13 Other secondary kyphosis (Cervicothoracic region)	0.000	0.999	0.001
M40.12 Other secondary kyphosis (Cervical region)	0.000	0.999	0.001
M40.11 Other secondary kyphosis (Occipito-atlanto-axial region)	0.000	0.999	0.001
M40.10 Other secondary kyphosis (Multiple sites in spine)	0.000	0.999	0.001
T91.8 Sequelae of other specified injuries of neck and trunk	0.000	0.999	0.001
J81 Pulmonary oedema	0.001	0.999	0.000
U84 Resistance to other antimicrobial drugs	0.001	0.999	0.000
U83 Resistance to other antibiotics	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations